Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial
Ophthalmology (Rochester, Minn.), 2013-11, Vol.120 (11), p.2300 [Peer Reviewed Journal]Copyright © 2013 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. ;EISSN: 1549-4713 ;DOI: 10.1016/j.ophtha.2013.06.020 ;PMID: 23916488
Digital Resources/Online E-Resources